Minimal SC-ß-Cell Properties for Transplantation in Diabetic Patients

Veronica Cochrane, Yini Xiao, Hasna Maachi, Matthias Hebrok

Research output: Chapter in Book/Report/Conference proceedingChapterpeer-review

Abstract

Pancreatic ß cells within the islets of Langerhans are the body’s main source for insulin. ß cells maintain glucose homeostasis through the tight control of insulin secretion and cessation in response to changes in blood glucose levels. The loss of ß cells or ß-cell dysfunction leads to the development of diabetes. Diabetes is a prevalent metabolic disease that affects populations worldwide. Considerable efforts are underway to develop therapies and treatments to combat diabetes. Transplantation of stem cell-derived ß cells (SC-ß cells) is a promising cell replacement therapy for curing diabetes. Significant advancements have been made toward generating functional SC-ß cells in laboratories. Here, we describe the essential properties of human ß cells that need to be reproduced in stem cell-derived insulin-producing cells to ensure functionality and safety.

Original languageEnglish
Title of host publicationPluripotent Stem Cell Therapy for Diabetes, First Edition
PublisherSpringer International Publishing
Pages529-545
Number of pages17
ISBN (Electronic)9783031419430
ISBN (Print)9783031419423
DOIs
StatePublished - 1 Jan 2024

Keywords

  • Ca signaling
  • Clinical trial
  • Diabetes
  • First-phase and second-phase insulin secretion
  • Insulin secretion
  • Islets of Langerhans
  • Metabolism
  • SC-ß cells
  • ß cells
  • ß-cell maturation

Fingerprint

Dive into the research topics of 'Minimal SC-ß-Cell Properties for Transplantation in Diabetic Patients'. Together they form a unique fingerprint.

Cite this